Netelenbos J C, Lems W F, Geusens P P, Verhaar H J, Boermans A J M, Boomsma M M, Mulder P G H, Papapoulos S E
Department of Endocrinology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands.
Osteoporos Int. 2009 Aug;20(8):1347-52. doi: 10.1007/s00198-008-0801-1. Epub 2008 Nov 28.
In women older than 60 years with clinical risk factors for osteoporosis but without osteoporosis based on bone mineral density (T-score >or= -2.5), a systematic survey with X-rays of the spine identified previously unknown vertebral deformities in 21% of women.
This study determines the prevalence of vertebral deformities in elderly women with clinical risk factors for osteoporosis but with BMD values above the threshold for osteoporosis (T-score >or= -2.5).
Bisphosphonate naïve women older than 60 years attending 35 general practices in the Netherlands with >or=2 clinical risk factors for osteoporosis were invited for BMD measurement (DXA). In women with T-score >or= -2.5 at both spine and the hips, lateral radiographs of the thoracic and lumbar spine were performed.
Of 631 women with a DXA measurement, 187 (30%) had osteoporosis (T-score < -2.5 at the spine or the hip). Of the remaining 444 women with T-score >or= -2.5 at both spine and hip, 387 had additional spine radiographs, of whom 80 (21%) had at least one vertebral deformity.
In elderly women with clinical risk factors for osteoporosis but BMD T-score >or= -2.5, addition of spine radiographs identified vertebral deformities in 21% (95% CI: 17-25). Since these women are at risk of future fractures, antiosteoporotic treatment should be considered.
在60岁以上有骨质疏松临床风险因素但根据骨密度(T值≥ -2.5)无骨质疏松的女性中,一项对脊柱进行X线检查的系统调查发现21%的女性存在此前未知的椎体畸形。
本研究确定有骨质疏松临床风险因素但骨密度值高于骨质疏松阈值(T值≥ -2.5)的老年女性中椎体畸形的患病率。
邀请荷兰35家普通诊所中60岁以上未使用过双膦酸盐且有≥2个骨质疏松临床风险因素的女性进行骨密度测量(双能X线吸收法)。对于脊柱和髋部T值均≥ -2.5的女性,进行胸腰椎侧位X线片检查。
在631名进行双能X线吸收法测量的女性中,187名(30%)患有骨质疏松(脊柱或髋部T值< -2.5)。在其余脊柱和髋部T值均≥ -2.5的444名女性中,387名进行了额外的脊柱X线片检查,其中80名(21%)至少有一处椎体畸形。
在有骨质疏松临床风险因素但骨密度T值≥ -2.5的老年女性中,加做脊柱X线片检查发现21%(95%可信区间:17 - 25)的女性存在椎体畸形。由于这些女性有未来骨折的风险,应考虑进行抗骨质疏松治疗。